Access the full text.
Sign up today, get DeepDyve free for 14 days.
Orthotopic heart
M. Medof, T. Kinoshita, V. Nussenzweig (1984)
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranesThe Journal of Experimental Medicine, 160
A. Zaidi, M. Schmoeckel, F. Bhatti, P. Waterworth, M. Tolan, E. Cozzi, G. Chavez, G. Langford, S. Thiru, J. Wallwork, D. White, P. Friend (1998)
Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors.Transplantation, 65 12
M. Sandrin, W. Fodor, Effie Mouthtouris, N. Osman, S. Cohney, S. Rollins, E. Guilmette, E. Setter, S. Squinto, I. Mckenzie (1995)
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysisNature Medicine, 1
Y. Sugita, Y. Nakano, M. Tomita (1988)
Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels.Journal of biochemistry, 104 4
T. Seya, J. Turner, J. Atkinson (1986)
Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4bThe Journal of Experimental Medicine, 163
A. Dalmasso, J. Platt (1993)
Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.Transplantation, 56 5
A. Reboul, M. Prandini, M. Colomb (1987)
Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties.The Biochemical journal, 244 1
M. Tanemura, S. Miyagawa, S. Koyota, M. Koma, H. Matsuda, S. Tsuji, R. Shirakura, N. Taniguchi (1998)
Reduction of the Major Swine Xenoantigen, the α-Galactosyl Epitope by Transfection of the α2,3-Sialyltransferase Gene*The Journal of Biological Chemistry, 273
S. Miyagawa, H. Hirose, R. Shirakura, Yoshihumi Naka, S. Nakata, Y. Kawashima, T. Seya, M. Matsumoto, A. Uenaka, H. Kitamura (1988)
THE MECHANISM OF DISCORDANT XENOGRAFT REJECTIONTransplantation, 46
Alan SGmREIBE, Allen, P., Kaplan, K., Frank Austen (1973)
Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.The Journal of clinical investigation, 52 6
(2000)
duction of transgenic pigs expressing human DAF ( CD 55 ) regulated by the porcine MCP promoters
S. Miyagawa, R. Shirakura, K. Iwata, S. Nakata, G. Matsumiya, H. Izutani, H. Matsuda, A. Terado, M. Matsumoto, S. Nagasawa, T. Seya (1994)
EFFECTS OF TRANSFECTED COMPLEMENT REGULATORY PROTEINS, MCP, DAF, AND MCP/DAF HYBRID, ON COMPLEMENT‐MEDIATED SWINE ENDOTHELIAL CELL LYSISTransplantation, 58
Z. Siddique, A. McPhaden, D. McCluskey, K. Whaley (1992)
A single base deletion from the C1-inhibitor gene causes type I hereditary angio-oedema.Human heredity, 42 4
R. Ziccardi (2004)
The first component of human complement (C1): Activation and controlSpringer Seminars in Immunopathology, 6
S. Miyagawa, R. Nakai, M. Yamada, M. Tanemura, Y. Ikeda, N. Taniguchi, R. Shirakura (1999)
Regulation of natural killer cell-mediated swine endothelial cell lysis through genetic remodeling of a glycoantigen.Journal of biochemistry, 126 6
S. Pruitt, W. Baldwin, H. Marsh, Shu-sen Lin, C. Yeh, R. Bollinger (1991)
THE EFFECT OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON HYPERACUTE XENOGRAFT REJECTIONTransplantation, 52
P. Harpel, T. Hugli, N. Cooper (1975)
Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edema.The Journal of clinical investigation, 55 3
A. Davis (1988)
C1 inhibitor and hereditary angioneurotic edema.Annual review of immunology, 6
J. Bergelson, J. Mohanty, R. Crowell, N. John, D. Lublin, R. Finberg (1995)
Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)Journal of Virology, 69
J. Bergelson, J. Mohanty, R. Crowell, N. John, D. Lublin, R. Finberg (1994)
Coxsackievirus B 3 Adapted to Growth in RD Cells Binds to Decay-Accelerating Factor ( CD 55 )
H. Murakami, H. Nagashima, Y. Takahagi, T. Fujimura, S. Miyagawa, M. Okabe, T. Seya, T. Shigehisa, N. Taniguchi, R. Shirakura, T. Kinoshita (2000)
Production of transgenic pigs expressing human DAF (CD55) regulated by the porcine MCP gene promoter.Transplantation proceedings, 32 7
A. Thall, P. Malý, J. Lowe (1995)
Oocyte Galα1,3Gal Epitopes Implicated in Sperm Adhesion to the Zona Pellucida Glycoprotein ZP3 Are Not Required for Fertilization in the Mouse (*)The Journal of Biological Chemistry, 270
K. Matsunami, S. Miyagawa, M. Yamada, M. Yoshitatsu, R. Shirakura (2000)
A surface-bound form of human C1 esterase inhibitor improves xenograft rejection.Transplantation, 69 5
K. McCurry, D. Kooyman, C. Alvarado, A. Cotterell, Michael Martin, J. Logan, J. Platt (1995)
Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injuryNature Medicine, 1
I. Šimonović, P. Patston (2000)
The native metastable fold of C1-inhibitor is stabilized by disulfide bonds.Biochimica et biophysica acta, 1481 1
Bill Brizzard, R. Chubet, D. Vizard (1994)
Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution.BioTechniques, 16 4
M. Coutinho, K. Aulak, A. Davis (1994)
Functional analysis of the serpin domain of C1 inhibitor.Journal of immunology, 153 8
M. Yoshitatsu, S. Miyagawa, S. Mikata, K. Matsunami, M. Yamada, A. Murase, Y. Sawa, S. Ohtake, H. Matsuda, R. Shirakura (1999)
Function of human factor H and I on xenosurface.Biochemical and biophysical research communications, 265 2
R. Tearle, M. Tange, Z. Zannettino, Marina Katerelos, T. Shinkel, B. Denderen, A. Lonie, I. Lyons, M. Nottle, T. Cox, C. Becker, A. Peura, P. Wigley, Robert Crawford, Allan Robins, Martin Pearse, A. D'apice (1996)
The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation.Transplantation, 61 1
J. Platt (1998)
New directions for organ transplantation.Nature, 392 6679 Suppl
T. Ward, P. Pipkin, N. Clarkson, D. Stone, P. Minor, J. Almond (1994)
Decay‐accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno‐focal cloning method.The EMBO Journal, 13
S. Mikata, S. Miyagawa, M. Yoshitatsu, M. Ikawa, M. Okabe, H. Matsuda, R. Shirakura (1998)
Prevention of hyperacute rejection by phosphatidylinositol-anchored mini-complement receptor type 1.Transplant immunology, 6 2
K. Matsunami, S. Miyagawa, R. Nakai, M. Yamada, R. Shirakura (2002)
Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis1Transplantation, 73
W. Fodor, B. Williams, L. Matis, J. Madri, S. Rollins, J. Knight, W. Velander, S. Squinto (1994)
Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.Proceedings of the National Academy of Sciences of the United States of America, 91 23
Brigitte Heckl-??streicher, A. Wosnik, Michael Kirschfink (1996)
Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1. Analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection.Transplantation, 62 11
P. Moran, H. Beasley, A. Gorrell, E. Martin, P. Gribling, H. Fuchs, N. Gillett, L. Burton, I. Caras (1992)
Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo.Journal of immunology, 149 5
C. Korzeniewski, D. Callewaert (1983)
An enzyme-release assay for natural cytotoxicity.Journal of immunological methods, 64 3
E. Cozzi, G. Langford, Andrew Richards, K. Elsome, R. Lancaster, P. Chen, N. Yannoutsos, David White (1994)
Expression of human decay accelerating factor in transgenic pigs.Transplantation proceedings, 26 3
T. Martino, M. Petric, M. Brown, K. Aitken, C. Gauntt, C. Richardson, L. Chow, P. Liu (1998)
Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.Virology, 244 2
(2001)
GlcNAc-R) in xenotransplantation
H. Friedl, Gerd Till, O. Trentz, Peter Ward (1989)
Roles of histamine, complement and xanthine oxidase in thermal injury of skin.The American journal of pathology, 135 1
Niwa Hitoshi, Yamamura Ken-ichi, M. Jun-ichi (1991)
Efficient selection for high-expression transfectants with a novel eukaryotic vector.Gene, 108 2
S. Miyagawa, H. Murakami, Y. Takahagi, R. Nakai, M. Yamada, Ayako Murase, S. Koyota, M. Koma, K. Matsunami, D. Fukuta, T. Fujimura, T. Shigehisa, M. Okabe, H. Nagashima, R. Shirakura, N. Taniguchi (2001)
Remodeling of the Major Pig Xenoantigen by N-Acetylglucosaminyltransferase III in Transgenic Pig*The Journal of Biological Chemistry, 276
(1998)
using genetically modified donors
S. Mikata, S. Miyagawa, K. Iwata, S. Nagasawa, M. Hatanaka, M. Matsumoto, W. Kamiike, H. Matsuda, R. Shirakura, T. Seya (1998)
Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein.Transplantation, 65 3
M. Schmoeckel, Farah Bhatti, A. Zaidi, E. Cozzi, P. Waterworth, M. Tolan, G. Pino-Chavez, Martin Goddard, R. Warner, G. Langford, John Dunning, J. Wallwork, David White (1998)
Orthotopic heart transplantation in a transgenic pig-to-primate model.Transplantation, 65 12
Uri Galili (2001)
The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation.Biochimie, 83 7
(2001)
The a-gal epitope (the Gal a1-3 Gal b 1-4 GlcNAc-R) in xenotransplantation
HARPEL (1975)
Studies on human plasma C1 inactivator-enzyme interactionJ Clin Invest, 55
Adam Asch, Taroh Kinoshita, Eric Jaffe, Victor Nussenzweig (1986)
Decay-accelerating factor is present on cultured human umbilical vein endothelial cellsThe Journal of Experimental Medicine, 163
A. Nicholson‐Weller, J. Burge, D. Fearon, P. Weller, K. Austen (1982)
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.Journal of immunology, 129 1
Bogdan Nowicki, Audrey Hart, Katharine Coyne, D. Lublin, S. Nowicki (1993)
Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interactionThe Journal of Experimental Medicine, 178
Fukuta D, Miyagawa S, Yamada M, Matsunami K, Kurihara T, Shirasu A, Hattori H, Shirakura R. Effect of various forms of the C1 esterase inhibitor (C1‐INH) and DAF on complement mediated xenogeneic cell lysis. Xenotransplantation 2003; 10: 132–141. © Blackwell Munksgaard, 2003 The purpose of the present study was to assess the effect of various forms of the surface‐bound form of the C1 esterase inhibitor (C1‐INH‐PI) and decay accelerating factor (DAF) on xenogenic cells. cDNAs of various deletion mutants of the C1‐INH‐PI, such as delta‐1‐99 amino acid (AA), delta‐108‐183AA loop, delta‐whole loop, delta‐exon5, delta‐exon6 + 7, and delta‐exon5 + 6 + 7, and that of DAF, the delta‐short consensus repeat (SCR) 1‐DAF were established. While all deletion mutants of C1‐INH‐PI except the delta‐1‐99AA were expressed in the cytoplasm but not on the cell surface, the delta‐1‐99AA was clearly expressed on the xenogeneic cell surface. Amelioration of complement‐mediated xenogeneic cell lysis by delta‐1‐99AA was next tested, and compared with delta‐SCR1 DAF. Both molecules blocked human complement‐mediated cell lysis by approximately 57 to 90 and 93 to 98%, respectively, in Chinese hamster ovarian tumor (CHO) cells and pig endothelial cells (PECs). The CHO cell transfectants were incubated with 20% normal human serum, and the amounts of C4 and C3 deposition on the cell surface were analysed by flow cytometry. The DAF transfectant showed a large amount of C4‐deposition and much less C3‐deposition than the controls (approximately 85% suppression), whereas the delta‐1‐99AA showed approximately a 40% suppression in both C4‐ and C3‐deposition. Consequently, both the delta‐1‐99AA C1‐INH‐PI and delta‐SCR1 DAF molecules are quite effective in down‐regulating the xenogeneic cell lysis, but accomplished this in different manners.
Xenotransplantation – Wiley
Published: Mar 1, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.